Fraxel FTX brings a new design, enhanced treatment delivery, and ergonomic updates to skin resurfacing practices.
Bausch Health Companies Inc and its aesthetics business, Solta Medical, launched Fraxel FTX, a skin resurfacing laser, at the 2025 American Society for Laser Medicine & Surgery Conference in Orlando.
This event began the rollout of Fraxel FTX to dermatologists, plastic surgeons, and other licensed aesthetic professionals across the United States, with plans to expand globally in the coming months.
Fraxel is skin rejuvenation treatment, addressing common skin concerns such as sun damage, wrinkles, acne scars, and pigmentation irregularities. Designed to offer an even more precise, efficient, and comfortable treatment experience, this next-generation product provides dermatologists and aesthetic professionals with advanced tools and is designed to deliver noticeable results after a single treatment in all skin types.
“We are pleased to unveil Fraxel FTX at the ASLMS 2025 Conference,” says Thomas J. Appio, CEO of Bausch Health, in a release. “This improved technology marks a significant milestone in our commitment to advancing aesthetic medicine and enhancing the patient experience. Fraxel FTX embodies our dedication to providing healthcare professionals with the cutting-edge tools they need to help deliver exceptional care.”
Key features and benefits of Fraxel FTX:
- Dual Wavelength Fractional Laser: Fraxel FTX utilizes a fractional laser system that targets aging and sun-damaged skin, leaving surrounding healthy tissue intact to promote rapid healing. The 1550 nm erbium-glass laser and 1927 nm thulium laser treat superficial and deeper skin layers.
- Redesigned Ergonomic Handpiece: Featuring a 20% reduction in weight and size and new integrated cooling technology, Fraxel FTX is designed for patient comfort during treatment.
- Visible Results with Minimal Downtime: Patients can expect noticeable improvements in skin texture, tone, and clarity with minimal disruption to their daily routines.
- Fast Tracking Experience: Intelligent Optical Tracking with AccuTRAC provides efficient and consistent treatment delivery utilizing patented technology for efficient firing of the laser.
- Redesigned Console: A modern design with an integrated arm and cable assembly.
- Refreshed User Interface: The redesigned color touchscreen and user interface are designed for flexible, personalized treatment settings, catering to aesthetic goals, as well as common skin concerns due to sun damage and aging.
“Fraxel FTX retains its trusted, proven laser technology offering customized treatments to deliver noticeable results, while combining a modern design, ergonomic enhancements, and efficiency to support today’s aesthetic practices,” says Jiny Kim, senior vice president of Solta Medical, Bausch Health, in a release.
The Fraxel FTX laser system received US Food and Drug Administration clearance in August 2024.
ID 174021995 © Dmytro Dudchenko | Dreamstime.com
